Modulation of the natriuretic peptide system in heart failure:from bench to bedside?

Schmitt, Matthias, Cockcroft, John R and Frenneaux, Michael P (2003) Modulation of the natriuretic peptide system in heart failure:from bench to bedside? Clinical Science, 105 (2). pp. 141-60. ISSN 0143-5221

Full text not available from this repository. (Request a copy)

Abstract

Since the discovery of atrial natriuretic peptide, the unravelling of the natriuretic peptide system has been a story of scientific success. However, bridging the gap between bench and bedside has proved difficult, and as yet has not provided any major clinical progress. In this review we will first give a detailed outline of the key elements constituting the natriuretic peptide system. Secondly, we will briefly explain the underlying rationale, basic concepts and evidence behind currently pursued strategies to potentiate the natriuretic peptide system. Thirdly, we will highlight some of the problems that have so far hindered successful translation of these theoretically viable treatment options into tangible clinical progress.

Item Type: Article
Uncontrolled Keywords: animals,atrial natriuretic factor,cardiotonic agents,heart failure,humans,mice,natriuretic peptide, brain,natriuretic peptide, c-type,peptide hormones
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 09 Mar 2015 07:30
Last Modified: 21 Apr 2020 23:54
URI: https://ueaeprints.uea.ac.uk/id/eprint/52455
DOI: 10.1042/CS20030044

Actions (login required)

View Item View Item